Last reviewed · How we verify

NCT03364855: SEBT

Star Excursion Balance for Patellofemoral Pain Syndrome

Status unknown NA Last updated 17 January 2018
What this trial tests

NA trial testing Star excursion balance test in Patellofemoral Pain Syndrome in 72 participants. Status unknown.

Timeline
12 January 2018
Primary endpoint
1 March 2018
1 March 2018

Quick facts

Lead sponsorUfuk University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment72
Start date12 January 2018
Primary completion1 March 2018
Estimated completion1 March 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ufuk University

Who can join

Adults 20 to 50, any sex, with Patellofemoral Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patellofemoral pain syndrome (PFPS) is a common and painful musculoskeletal condition that affects physically active young adults and causes pain front of the knee. Patients with PFPS has bilateral impairment in proprioception, as well as more in the affected knee than the normal; also the decrease of muscular strength, range of motion, and neuromuscular control are known to result with impaired static and dynamic balance.This study aimed to investigate the efficacy of a-four week YDT balance exercises on pain, quality of life and functional state in patients with PFPS with impaired balance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Patellofemoral Pain Syndrome

Currently open trials in the same condition.

Other Ufuk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03364855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing